35
Views
1
CrossRef citations to date
0
Altmetric
Articles

Chronic obstructive pulmonary disease: the contribution of skeletal muscle dysfunction to exercise intolerance

Pages 62-66 | Published online: 19 Jul 2013
 

Abstract

Chronic obstructive pulmonary disease (COPD) is characterised by pathological changes in lung tissue and disordered respiratory mechanics. The exercise intolerance exhibited by individuals with COPD is related to a variety of factors including airflow obstruction, pulmonary hyperinflation, gas exchange abnormalities, and peripheral muscle dysfunction. This review examines the extent of skeletal muscle dysfunction in moderate-to-severe COPD, and its relationship to exercise intolerance. There are two distinct characteristics of skeletal muscle dysfunction in COPD – loss of muscle mass and dysfunction of the remaining muscle tissue. Abnormalities have been identified in the structural and functional determinants of skeletal muscle function (strength and endurance), and are also observed in the enzymatic profile and metabolic response to exercise in subjects with the disease. Understanding the nature of skeletal muscle dysfunction in COPD is critical to the interpretation of exercise performance in affected subjects. Furthermore, skeletal muscle dysfunction represents a partially reversible consequence of COPD, that may be ameliorated by specific exercise training strategies.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.